CSPC PHARMA

1093
8.1000.87% ( +0.070 )
Delay Closed: Nov 16, 16:08:11

Financials

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: CSPC PHARMA(01093) the Revenue is 14.13 B (+107.4%), Beat estimate;the EBIT is 7.43 B (+542.6%), Beat estimate;the EPS is 0.534 (+422.9%), Beat estimate.

Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
14.13B107.44%
10.11B48.53%
+4.01B58.91%
EBITExceed expectations
7.43B542.60%
3.77B226.40%
+3.66B316.20%
EPSExceed expectations
0.5337422.91%
0.3585251.26%
+0.1752171.65%

Upcoming earnings report - FY2026 9 Months Earning Release

Available dateNov 18, 2026
Estimate Revenue7.687 B
Estimate EBIT951.46 M
Estimate EPS0.0936

Revenue

ActualEstimateUnit: HKD
Quarterly

EBIT

ActualEstimateUnit: HKD
Quarterly

Net income

ActualEstimateUnit: HKD
Quarterly

EPS

ActualEstimateUnit: HKD
Quarterly